NLRX1

Gene2 papers2 findingsHGNC 29890NCBI Gene 79671Taxon 9606

C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.

A gene’s or a process’s line counts the gene with the processes named after it, as NLRP3 with the NLRP3 inflammasome, and the trials of drugs aimed at it.

1 lab in 1 country

Funders: National Natural Science Foundation of China and 4 more

  • Animals2

Effects

2

Oxidative phosphorylation

upin mouse cells1

1 study
  1. NLRX1 improves oxidative phosphorylation in mouse cells.

    Cellssenescence-inducing conditions

    Ubiquitination-mediated degradation of NLRX1 drives metabolic vulnerability and accelerates intervertebral disc degeneration · Cell death and differentiation · 23 Sep 2026

Oxidative phosphorylation →

Intervertebral disc degeneration

downin mice1

1 study
  1. NLRX1 protects against intervertebral disc degeneration in mice.

    Animalsshown by knockout

    Ubiquitination-mediated degradation of NLRX1 drives metabolic vulnerability and accelerates intervertebral disc degeneration · Cell death and differentiation · 23 Sep 2026

Intervertebral disc degeneration →

Funding

National Institute on AgingUS$351.8k1 grant since 2024

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 02